Recombinant Human Vascular Endothelial Growth Factor,CHO
規(guī)格:
數(shù)量:
價(jià)格:
折后價(jià):
金牌價(jià)格:
聯(lián)系客服:
英文名稱:Recombinant Human Vascular Endothelial Growth Factor,CHO
中文簡(jiǎn)稱:【VEGF CHO】重組人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá)
Recombinant Human Vascular Endothelial Growth Factor,CHO 【VEGF CHO】重組人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá) 細(xì)胞因子產(chǎn)品描述:
血管內(nèi)皮生長(zhǎng)因子(Vascular endothelial growth factor,VEGF)是血管內(nèi)皮細(xì)胞特異性的肝素結(jié)合生長(zhǎng)因子(heparin-binding growth factor),可在體內(nèi)誘導(dǎo)血管新生。VEGF有六種不同亞型,包括VEGF-A,-B,-C,-D,及-E;其分子量從35至44kDa不等,每個(gè)亞型特異性地與三個(gè)“血管內(nèi)皮生長(zhǎng)因子受體”(VEGFR-1,-2,及-3)的特定組合相結(jié)合。VEGF是高度保守的同源二聚體糖蛋白。二條分子量各為24kDa的單鏈以二硫鍵組成二聚體。VEGF分解的單體無(wú)活性,去除N 2糖基對(duì)生物效應(yīng)無(wú)影響,但可能在細(xì)胞分泌中起作用。由于mRNA不同的剪切方式,產(chǎn)生出分別VEGF121、VEGF145、VEGF165、VEGF185、VEGF206等至少5種蛋白形式,其中VEGF121、VEGF145、VEGF165是分泌型可溶性蛋白,能直接作用于血管內(nèi)皮細(xì)胞促進(jìn)血管內(nèi)皮細(xì)胞增殖,增加血管通透性。
人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá)重組蛋白是在CHO中國(guó)倉(cāng)鼠卵巢細(xì)胞中重組表達(dá)的,是由兩條糖基化多肽鏈構(gòu)成的同源二聚體。包含有165個(gè)氨基酸殘基。由于發(fā)生了糖基化修飾,其在SDS-PAGE電泳顯示分子量為44kDa。該人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá)重組蛋白最終由標(biāo)準(zhǔn)的色譜技術(shù)純化出。
來源宿主---CHO中國(guó)倉(cāng)鼠卵巢細(xì)胞中重組表達(dá)
Recombinant Human Vascular Endothelial Growth Factor,CHO 【VEGF CHO】重組人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá) 細(xì)胞因子產(chǎn)品使用須知:
溶解:提供的人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá)(VEGF CHO)產(chǎn)品為過濾滅菌的白色凍干粉末;該凍干粉末是從含人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá)(VEGF CHO)的磷酸鹽緩沖鹽水(pH 7.4)中凍干產(chǎn)生的。我們建議加無(wú)菌的18MΩ-cm水以配制工作儲(chǔ)存液到不低于100ug/ml,后繼實(shí)驗(yàn)過程中可根據(jù)實(shí)驗(yàn)要求進(jìn)一步稀釋。
保存:人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá)(VEGF CHO)在室溫可保存3周,或置于-18℃凍存用于長(zhǎng)期保存。重新溶解后可以在4℃冷藏保存至少2-7天;如果想延長(zhǎng)保存時(shí)間,建議分裝(加載體蛋白如0.1% HSA或 BSA)后置于-18℃凍存。請(qǐng)避免反復(fù)凍融。
Recombinant Human Vascular Endothelial Growth Factor,CHO 【VEGF CHO】重組人血管內(nèi)皮生長(zhǎng)因子,CHO表達(dá) 細(xì)胞因子產(chǎn)品英文描述:
Synonyms
Vascular endothelial growth factor A, VEGF-A, Vascular permeability factor, VPF, VEGF, MGC70609.
Introduction
Vascular endothelial growth factor is an important signaling protein involved in both vasculogenesis and angiogenesis. As its name implies, VEGF activity has been mostly studied on cells of the vascular endothelium, although it does have effects on a number of other cell types (e.g. stimulation monocyte/ macrophagemigration, neurons, cancer cells, kidney epithelial cells ). VEGF mediates increased vascular permeability, induces angiogenesis, vasculogenesis and endothelial cell growth, promotes cell migration, and inhibits apoptosis. In vitro, VEGF has been shown to stimulate endothelial cell mitogenesisand cell migration. VEGF is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor.
Elevated levels of this protein are linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy.
Description
Vascular Endothelial Growth Factor Human Recombinant produced in CHO cells is a double, glycosylated, polypeptide chain containing 165 amino acids and migrates as 44 kDa in SDS-PAGE under non-reducing conditions.
The VEGF is purified by proprietary chromatographic techniques.
Source
Chinese Hamster Ovarian Cell.
Physical Appearance (外觀)
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation
The protein was lyophilized from a Phosphate- Buffered Saline, pH 7.4.
Solubility (溶解性)
It is recommended to reconstitute the lyophilized Vascular Endothelial Growth Factor Human in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
Stability (穩(wěn)定性)
Lyophilized Vascular Endothelial Growth Factor Human although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution VEGF Human Recombinant should be stored at 4°C between 2-7 days and for future use below -18°C.
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.
Purity (純度)
Greater than 97.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Biological Activity (生物活性)
Determined by its ability to stimulate 3H-Thymidine incorporation in human ublical vein endothelial cells, the ED50 for this effect was found to be 2-6ng/ml, corresponding to a Specific Activity of 166,667-500,000IU/mg.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
OriGen CP-70 CryoPur-DMSO 細(xì)胞凍存液 二甲基亞砜 進(jìn)口USP級(jí) CE認(rèn)證 CP70
¥1Lifeline LL-0002 VascuLife EnGS Complete Kit 人內(nèi)皮細(xì)胞培養(yǎng)基套裝
¥1Anti-Human CD4 PerCP-Cyanine5.5 人CD4抗體
¥4,188Corning 88-571-kit Natural Killer Cell Serum-free Culture Kit II NK細(xì)胞活化擴(kuò)增培養(yǎng)基套裝
¥0Cellartis Y50200 MSC Xeno-Free Culture Medium 人間充質(zhì)干細(xì)胞培養(yǎng)基,無(wú)外源無(wú)需包被
¥1Origen CS250 Freezing Bags vol-max 30-70mL 凍存袋 細(xì)胞治療用藥包材
¥1華雅智能科技」王炸新品來襲!MAP懸浮細(xì)胞培養(yǎng)瓶,重新定義你的培養(yǎng)體驗(yàn)!
華雅懸浮細(xì)胞培養(yǎng)瓶:以國(guó)產(chǎn)價(jià)格,享進(jìn)口品質(zhì)的細(xì)胞培養(yǎng)革新方案
科研專用:HySmart Labs華雅智能科技MAP30-R懸浮細(xì)胞培養(yǎng)瓶選購(gòu)指南
替代搖瓶:HySmart Labs華雅智能科技 MAP30-R懸浮細(xì)胞培養(yǎng)瓶的三大優(yōu)勢(shì)
ProteanFect CRISPRMax 轉(zhuǎn)染試劑盒(適用于多種原代細(xì)胞與難轉(zhuǎn)染細(xì)胞系)(西湖凝聚體)
【臍帶血干細(xì)胞新藥獲批】CryoStore? 25為干細(xì)胞治療保駕護(hù)航
首款干細(xì)胞治療藥品已上市!OriGen凍存袋助力MSC藥物研發(fā)
ProteanFect:小鼠原代T細(xì)胞從提取到轉(zhuǎn)染全流程攻略
貼壁細(xì)胞轉(zhuǎn)染優(yōu)選:ProteanFect轉(zhuǎn)染試劑盒 現(xiàn)貨代理
ProteanFect和Lipo系列轉(zhuǎn)染試劑的區(qū)別,怎么選擇?